TMED Biosciences · TM & ED Platform
Translational Medicine and Early Clinical Development solutions to bridge the valley of death, from bench to bedside, and raise drug approval rates.
90% of drugs that enter clinical trials fail. Most of these failures stem not from flawed science, but from a suboptimal process of translating discoveries into actual cures. These translational medicine failures — the wrong patient, the wrong biomarker, the wrong design — are what skilled, experienced experts know how to solve.
Talent Marketplace
The only platform built exclusively for translational medicine and early clinical development, matching specialized professionals with opportunities.
Premium Search
A bespoke, guarantee-backed search conducted by professionals who understand your program.
Service on Demand
Expert-produced, AI-assisted scientific deliverables — biomarker strategies, CDx roadmaps, IND-enabling plans, and many more.
01
Every match, every deliverable, and every recommendation is reviewed by a domain expert before it reaches you.
02
We define success before we begin. Our satisfaction guarantee is anchored to a written success definition agreed with every client.
03
From IND-enabling science through regulatory approval — one platform, every role the valley of death requires.
04
Our AI platform is trained by the experts — on real program decisions, real biomarker strategies, and real regulatory challenges.
Whether you are an expert offering your expertise or a pharma team that needs it — TMED Biosciences was built for you.
Questions? We respond within one business day.
Talent Marketplace
Connecting translational medicine and early clinical development talent with high-impact opportunities. Facilitating strategic networking and delivering tailored professional value.
Register your profile, set your availability and compensation expectations, and let the platform match you to programs that need exactly what you offer.
Post an opportunity and receive a matched pool of highly qualified translational medicine and early development talent that your program needs.
The TMED Biosciences Talent Marketplace covers the complete expert landscape from IND-enabling science through regulatory approval.
01
Translational Science
Target biology, MOA, disease models, PK/PD, IND-enabling science
02
Clinical Biomarkers
Patient stratification, enrichment design, biomarker strategy, PGx
03
Biomarker Technologies
Assay development, platform selection, CRO oversight
04
Companion Diagnostics
CDx strategy, IVD development, PMA/510(k), co-submission planning
05
Data Science & Bioinformatics
Multi-omic integration, patient stratification algorithms, RWD analysis
06
Early Clinical Development
FIH design, dose escalation, PoC strategy
07
Clinical Science
Protocol design, study execution, CRF development, data review
08
Medical Affairs
KOL engagement, scientific communications, MSL strategy, label input
09
Regulatory Affairs
IND, CDx co-submission, FDA/EMA dialogue
Premium Search
A bespoke, guarantee-backed search conducted by professionals who understand your program.
01
Before we search, we sit with you for 45 minutes and answer one question: what does this engagement look like if it goes exactly right? That answer becomes the benchmark for our guarantee.
02
We present a maximum of three candidates, each with a written recommendation explaining specifically why this expert fits your program. You receive our judgment, not a list.
03
Our four-stage assessment tests scientific capability, communication under pressure, drive, and the ability to engage with and motivate cross-functional teams. Credentials are a starting point, not the be-all and end-all.
04
If the engagement is not delivering against the agreed success definition by day 60, we conduct a replacement search at no additional cost.
Interest submitted
The search begins.
Your interest triggers a brief call within 48 hours.
Brief call
45 min. Success defined in writing.
What does this engagement look like if it goes exactly right?
Search
Expert Network first.
Our vetted roster is searched before any external outreach.
Shortlist · Day 14
2–3 candidates. Written rec for each.
Not a list of CVs — a curated recommendation for each expert.
Placement
You select. We introduce.
180-day guarantee active from day one.
Premium Search
Answer the questions below as specifically as possible. The more context you provide, the faster and sharper our search will be.
What happens next
Questions?
We respond within one business day. Reach us directly via the contact form.
Service on Demand
Expert-produced, AI-assisted scientific deliverables. 8–12 weeks. You manage the output, not the team that produced it.
No charge
Scoping call. 60 minutes.
We confirm what you need, agree the scope, and define success. Both sides confirm before anything begins.
Signed
Statement of work. Signed by both sides.
Delivery only begins after sign-off.
Internal
Our expert team works.
Professionally led, knowledge-base-powered, AI-assisted. No need to manage a team.
Preview
Concept delivered.
Review it, give directional feedback, course-correct before the full build.
Closeout
Final deliverable. 60-minute call.
Confirmed against the agreed scope. Guaranteed.
Indication selection
Indication Selection and Prioritization Analysis
Not sure which indication to pursue first? We assess mechanism-indication fit, competitive positioning, patient stratification opportunity, and regulatory pathway — and recommend a prioritized indication strategy.
Biomarker strategy
Translational Biomarker Strategy Package
A complete biomarker strategy for your clinical development program — covering patient selection rationale, biomarker hypothesis, assay recommendations, and regulatory positioning.
Precision medicine
Patient Selection and Endotyping Framework
Define the patient populations most likely to respond — and the biological rationale for selecting them. Built for precision medicine programs that need to go beyond clinical staging.
IND-enabling
IND-Enabling Translational Plan
A structured translational plan covering the scientific rationale, non-clinical to clinical translation strategy, and IND readiness assessment for programs approaching first-in-human.
CDx strategy
Companion Diagnostic Strategy and Roadmap
From biomarker hypothesis through regulatory co-submission planning — a complete CDx strategy including assay platform recommendation, diagnostic partner landscape, and FDA/EMA pathway analysis.
Clinical design
Phase 1/2a Study Design Review and Optimization
An independent expert review of your Phase 1 or Phase 1/2a protocol. Dose escalation design, biomarker integration, PoC endpoint strategy, and regulatory defensibility — assessed and improved.
Competitive intelligence
Translational Competitive Landscape Analysis
Where does your program sit in the competitive landscape? We map the biomarker strategies, patient selection approaches, and regulatory precedents in your indication — and identify where your differentiation opportunity lies.
If any element of the agreed scope is missing or incomplete, we fix it within two weeks at no charge.
If the final deliverable does not meet the success definition agreed at the start, you have the right to one full revision cycle.
If at the concept stage the direction is fundamentally misaligned with your needs, you may exit the engagement.
Service on Demand
Select the deliverable you need, tell us what you can provide, and we'll take it from there.
What happens next
Questions?
We respond within one business day. Reach us directly via the contact form.
About
Where translational expertise meets the science of drug development — built to raise approval rates.
"Improving success of drug development. Delivering life-changing precision treatments to patients."
Pharmaceutical drug development fails 90% of the time. Not because the science is faulty — but because the translation from bench to bedside remains fundamentally disjointed. Wrong patient populations are enrolled. Biomarker strategies are underpowered. First-in-human designs do not capture the signal. These are translational medicine failures that skilled, experienced professionals know how to prevent.
TMED Biosciences is built on a founding belief that combining elite human expertise with artificial intelligence that understands the science — trained by domain experts, not just fed published literature — can raise drug approval rates from the current 10% to above 50%. That is not a small ambition. But it is a solvable problem.
tmedbio.com
TMED Biosciences connects translational medicine and early clinical development experts with programs that need them — through a talent marketplace, a bespoke premium search service, and expert-produced scientific deliverables.
Services
Joining as an expert? Register on the Talent Marketplace and
Ready to post an opportunity? Go to the Talent Marketplace to
Need a bespoke retained search? Start with
Don't want extra overheads? Explore the menu on
Talent Marketplace · Expert Registration
Complete your expert profile to be matched with programs that need exactly what you offer.
Why join the marketplace
Questions?
We respond within one business day. Reach us directly via the contact form.
Talent Marketplace
Tell us what your program needs. We'll match you with pre-vetted translational medicine and early development talent from our expert network.
What happens next
Questions?
We respond within one business day. Reach us directly via the contact form.
CURRENT NEED
Open engagements posted by client organizations. Register and log in to express interest.
Showing 6 of 6 opportunities
EXPERT NETWORK
Pre-vetted translational medicine and early development talent, organized by role cluster and available for engagement.
Showing 45 of 45 experts